Regulation of innate immune signaling by IRAK proteins

M Pereira, RT Gazzinelli - Frontiers in Immunology, 2023 - frontiersin.org
The Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1R) families are of paramount
importance in coordinating the early immune response to pathogens. Signaling via most …

IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial

L Ackerman, G Acloque, S Bacchelli, H Schwartz… - Nature Medicine, 2023 - nature.com
Toll-like receptor–driven and interleukin-1 (IL-1) receptor–driven inflammation mediated by
IL-1 receptor–associated kinase 4 (IRAK4) is involved in the pathophysiology of hidradenitis …

[PDF][PDF] Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with …

V Quagliariello, A Paccone, M Iovine… - European Review for …, 2021 - europeanreview.org
Cytokines in cardiac tissue plays a key role in progression of cardiometabolic diseases and
cardiotoxicity induced by several anticancer drugs. Interleukin-1β is one on the most studied …

[HTML][HTML] Pinostrobin ameliorates lipopolysaccharide (LPS)-induced inflammation and endotoxemia by inhibiting LPS binding to the TLR4/MD2 complex

AMGK Athapaththu, KT Lee, MHD Kavinda… - Biomedicine & …, 2022 - Elsevier
Pinostrobin is a natural flavonoid with valuable pharmacological properties, including anti-
cancer, anti-viral, and anti-oxidant activities. However, the anti-inflammatory effects of …

The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways

M Pereira, DF Durso, CE Bryant, EA Kurt-Jones… - Cell reports, 2022 - cell.com
Summary Interleukin-1 receptor-associated kinases (IRAKs)− 4,− 2, and− 1 are involved in
transducing signals from Toll-like receptors (TLRs) via the adaptor myeloid differentiation …

Discovery of KT-474─ a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases

X Zheng, N Ji, V Campbell, A Slavin… - Journal of Medicinal …, 2024 - ACS Publications
Interleukin-1 receptor associated kinase 4 (IRAK4) is an essential mediator of the IL-1R and
TLR signaling pathways, both of which have been implicated in multiple autoimmune …

Design, synthesis, and bioevaluation of novel MyD88 inhibitor c17 against acute lung injury derived from the virtual screen

P Chen, Y Zhou, X Li, J Yang, Z Zheng… - Journal of Medicinal …, 2023 - ACS Publications
Myeloid differentiation primary response protein 88 (MyD88) is crucial to immune cascades
mediated by Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). MyD88 …

An optogenetic method for the controlled release of single molecules

P Kashyap, S Bertelli, F Cao, Y Kostritskaia, F Blank… - Nature …, 2024 - nature.com
We developed a system for optogenetic release of single molecules in cells. We confined
soluble and transmembrane proteins to the Golgi apparatus via a photocleavable protein …

OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation

Y Liu, J Yuan, Y Zhang, F Qin, X Bai, W Sun… - Cell Death & …, 2024 - nature.com
Myddosome is an oligomeric complex required for the transmission of inflammatory signals
from TLR/IL1Rs and consists of MyD88 and IRAK family kinases. However, the molecular …

Myddosome clustering in IL‐1 receptor signaling regulates the formation of an NF‐kB activating signalosome

F Cao, R Deliz‐Aguirre, FHU Gerpott, E Ziska… - EMBO …, 2023 - embopress.org
Abstract IL‐1 receptor (IL‐1R) signaling can activate thresholded invariant outputs and
proportional outputs that scale with the amount of stimulation. Both responses require the …